Get started
Author

C. Damoci

Development of a Fully Human Anti-PDGFRβ Antibody That Suppresses Growth of Human Tumor Xenografts and Enhances Antitumor Activity of an Anti-VEGFR2 Antibody
2009 · Juqun Shen, Marie Danielle Vil, et al. · Neoplasia · 62
PDF
An antibody directed against PDGF receptor β enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody
2007 · Juqun Shen, Marie D. Vil, et al. · Biochemical and Biophysical Research Communications · 39
Addressing Biological Questions with Preclinical Cancer Imaging
2024 · Chris B. Damoci, Joseph R. Merrill, et al. · Cold Spring Harbor Perspectives in Medicine · 3
PDF
Abstract C159: A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth.
2013 · Maria Lebron, Laura Brennan, et al. · Molecular Cancer Therapeutics · 1
451 Two Insulin Receptor Isoforms Confer Intrinsic Resistance to the Antibody Against Insulin-like Growth Factor Receptor I
2012 · A. Forest, M. Amatulli, et al. · European Journal of Cancer
55 POSTER Combination therapy of an anti-PDGFRb antibody with an anti-VEGFR2 antibody leads to enhanced antitumor activity
2008 · J. Shen, M. Prewett, et al. · European Journal of Cancer Supplements
290 Pharmacokinetics and tissue biodistribution of a doxorubicin-antibody conjugate in mice
2004 · P. Sapra, G. Griffiths, et al. · European Journal of Cancer Supplements
299 Preclinical in vivo evaluation of a doxorubicin-antibody conjugate for treating multiple myeloma
2004 · G.L. Griffiths, P. Sapra, et al. · European Journal of Cancer Supplements
Therapeutic effects of anti-CEA (CEACAM5) and anti-NCA90 (CEACAM6) antibody monovalent fragments in vitro and in vivo
2004 · R. Blumenthal, M. Rodriguez, et al. · Journal of Clinical Oncology
Works count: 9
Citation count: 105
H-index: 3
I10-index: 2
Year
Topic
Type